PARP Inhibitor / CYP17 Inhibitor Combinations are used to treat certain types of prostate cancer. They work by decreasing levels of androgens in the body and preventing the tumor's DNA from repairing itself properly.
Why are parp inhibitor cyp17 inhibitor combinations prescribed?
How are these percentages calculated?These percentages are created by aggregating the total number of claims for the drugs in this class divided by the # of drugs with a specific indication. It is meant to be representative but may not accurately reflect the actual # of prescriptions written to treat specific condition.
Prices for popular PARP Inhibitor / CYP17 Inhibitor Combinations medications
NIRAPARIB; ABIRATERONE treats prostate cancer. It works by decreasing levels of the hormone testosterone in the body. It also blocks a protein that causes cancer cells to grow and multiply. This prevents prostate cancer cells from spreading or growing.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up